Therapeutics Bridge Labs (TxBL), launched by MSK in 2025 and embedded within OEC, represents a unique strategic asset among New York City academic research institutions.
We treat every type of cancer, including the most important one: yours. With cancer, where you get treated first matters. From diagnosis to treatment, our experts provide the care and support you need ...
Find a researcher or lab Education & training programs MSK Innovation MSK Commercialization Ecosystem ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results